Therapeutic Advances and Unmet Challenges in mCRPC

EP. 1: Introduction: Therapeutic Advances in mCRPC

May 28th 2014

EP. 2: AUA Castration-Resistant Prostate Cancer Guidelines

May 28th 2014

EP. 3: NCCN and AUA Prostate Cancer Guidelines

May 28th 2014

EP. 4: Role of Imaging in M0 CRPC

May 28th 2014

EP. 5: Preventing SREs in Prostate Cancer

May 28th 2014

EP. 6: Antiandrogen Monotherapy for mCRPC

May 28th 2014

EP. 7: Prognostic Biomarker Tests for Prostate Cancer

May 28th 2014

EP. 8: Biopsy, Biomarkers, and Imaging in Prostate Cancer

May 28th 2014

EP. 9: Biomarkers in the Management of Prostate Cancer

May 28th 2014

EP. 10: Evolution of Treatment for mCRPC

May 28th 2014

EP. 11: Multidisciplinary Approach to mCRPC Treatment

May 28th 2014

EP. 12: Treating Symptomatic Bone Metastatic CRPC

May 28th 2014

EP. 13: Oral Hormonal Agents for mCRPC

May 28th 2014

EP. 14: Treating mCRPC with Newer Hormonal Agents

May 28th 2014

EP. 15: Antiandrogens-Differences and Sequencing

May 28th 2014

EP. 16: Radium-223: Treatment Considerations

May 28th 2014

EP. 17: Sipuleucel-T in Castration-Resistant Prostate Cancer

May 28th 2014

EP. 18: Treatment Advances in Metastatic CRPC

May 28th 2014

EP. 19: SREs, Risk Stratification, and Agents in Development

May 28th 2014

EP. 20: Role of Nurses and Other Care Providers

May 28th 2014

NEXT PAGE
PREVIOUS PAGE